During the past decade, CAPRISA Aurum CRS conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CAPRISA Aurum CRS" #1 collaborator was "HIV Vaccine Trials Network" with 1 trials as a collaborator and "Microbicide Trials Network" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "CAPRISA Aurum CRS" are "HIV Infections" (3 trials). Many other conditions were trialed in "CAPRISA Aurum CRS" in a lesser frequency.

Most popular intervention types in "CAPRISA Aurum CRS" are "Biological" (2 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Emtricitabine/tenofovir disoproxil fumarate" (1 trials), "Emtricitabine/tenofovir disoproxil fumarate placebo" (1 trials), "MRKAd5 HIV-1 gag/pol/nef" (1 trials), "Placebo" (1 trials) and "Tenofovir 1% vaginal gel" (1 trials). Other intervention names were less common.

The vast majority of trials in "CAPRISA Aurum CRS" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "CAPRISA Aurum CRS". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in CAPRISA Aurum CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CAPRISA Aurum CRS, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".